LCRF Grant Helps Accelerate Study Launched by TGen that May Bring Hope to Patients

The research from a study funded by LCRF has assisted researchers at the Translational Genomics Research Institute (TGen) to discover a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.